Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Gold Nanoparticles as Novel Biomarkers for Cancer Stem Cells in Salivary Gland Tumors: A Diagnostic and Prognostic Accuracy Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04907422
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:31.299954+00:00
Published At
2021-09-01T00:00:00+00:00
Record Updated At
2021-09-01
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Carcinoma Ex Pleomorphic Adenoma of Salivary Glands", "Pleomorphic Adenoma of Salivary Glands"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2021-09-01"
protocolSection.identificationModule.nctId
"NCT04907422"
protocolSection.identificationModule.officialTitle
"Gold Nanoparticles as Novel Biomarkers for Cancer Stem Cells in Salivary Gland Tumors: A Diagnostic and Prognostic Accuracy Study"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Carcinoma Ex Pleomorphic Adenoma of Salivary Glands (protocolSection.conditionsModule.conditions)
  • Pleomorphic Adenoma of Salivary Glands (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.